Long-term exposition of cells to β-amyloid results in decreased intracellular calcium concentration

Neurochemistry International

Volumn 42, Issue 7, 2003, Pages 543-547

  Palotás, András ^a   Kálmán, János ^a   Palotás, Miklós ^a   Kemény, Lajos ^a   Janka, Zoltán ^a   Penke, Botond ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Amyloid; Alzheimer's disease; Calcium; Calcium antagonist; Fibroblast; Fluorimetry

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM ANTAGONIST; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM EXPOSURE; PRIORITY JOURNAL; PROTEIN FUNCTION;

AMYLOID BETA-PROTEIN; CALCIUM; FIBROBLASTS; FOREARM; HUMANS; INTRACELLULAR MEMBRANES; OSMOLAR CONCENTRATION; SKIN; TIME FACTORS;

EID: 12244311197     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00188-2     Document Type: Article

References (29)

1. Benveniste E.N., Nguyen V.T., O'Keefe G.M. Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem. Int. 39:2001;381-391.
2. Bisaglia M., Venezia V., Piccioli P., Stanzione S., Porcile C., Russo C., Mancini F., Milanese C., Schettini G. Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-KappaB activation. Neurochem. Int. 41:2002;43-54.
3. Connolly G.P. Fibroblast models of neurological disorders: fluorescence measurement studies. Trends Pharmacol. Sci. 19:1998;171-177.
4. Cowburn R.F., Wiehager B., Sundstrom E. β-Amyloid peptides enhance binding of the calcium mobilising second messengers: inositol-(1,4,5)trisphosphate and inositol (1,3,4,5)tetrakis-phosphate to their receptor sites in rat cortical membranes. Neurosci. Lett. 191:1995;31-34.
5. Eckert A., Cotman C.W., Zerfass R., Hennerici M., Muller W.E. Lymphocytes as cell model to study apoptosis in Alzheimer's disease: vulnerability to programmed cell death appears to be altered. J. Neural Trans. Suppl. 54:1998;259-267.
6. Harkany T., Abraham I., Timmerman W., Laskay G., Toth B., Sasvari M., Konya C., Sebens J.B., Korf J., Nyakas C., Zarandi M., Soos K., Penke B., Luiten P.G. β-Amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur. J. Neurosci. 12:2000;2735-2745.
7. Ishikawa H., Ozawa H., Saito T., Takahata N., Takemura H. Calcium mobilization evoked by amyloid β-protein involves inositol 1,4,5-triphosphate production in human platelets. Life Sci. 62:1998;705-713.
8. Kimura H., Shubert D. Amyloid-β protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate. Proc. Natl. Acad. Sci U.S.A. 90:1993;7508-7512.
9. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J., Guo L., Van Eldik L.J. Apolipoprotein E and apolipoprotein E receptors modulate a beta-induced glial neuroinflammatory responses. Neurochem. Int. 39:2001;427-434.
10. i in rat astrocytes. Biochem. Biophys. Res. Commun. 235:1997;479-481.
11. Li J.C., Kaminskas E. Deficient repair of DNA lesions in Alzheimer's disease fibroblasts. Biochem. Biophys. Res. Commun. 129:1985;733-738.
12. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol reagents. J. Biol. Chem. 193:1951;265-275.
13. Mattson M.P. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77:1997;1081-1132.
14. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16:1993;409-414.
15. 2+] in hippocampal neurons. NeuroReport. 9:1998;1553-1558.
16. Muller W.E., Koch S., Eckert A., Hartmann H., Scheuer K. β-Amyloid peptide decreases membrane fluidity. Brain Res. 674:1995;133-136.
17. Pákáski M., Baláspiri L., Checler F., Kása P. Human amyloid-β causes changes in the levels of endothelial protein kinase C and its alpha isoform in vitro. Neurochem. Int. 41:2002;409.
18. i-level of fibroblasts from Alzheimer patients and control individuals. Neurochem. Res. 26:2001;817-820.
19. Palotás A., Kálmán J., Palotás M., Juhász A., Janka Z., Penke B. β-Amyloid-induced increase in the resting intracellular calcium concentration gives support to tell Alzheimer lymphocytes from control ones. Brain Res. Bull. 58:2002;203-205.
20. Paoletti F., Tombaccini D. Proteolytic imbalance in Alzheimer fibroblasts as potential pathological trait of disease. FASEB J. 12:1998;925-927.
21. Pascale A., Etcheberrygaray R. Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities. Pharmacol. Res. 39:1999;81-88.
22. Perry R.H., Wilson I.D., Bober M.J., Atack J., Blessed G., Tomlinson B.E. Plasma and erythrocyte acetylcholinesterase in senile dementia of Alzheimer type. Lancet. 1:1982;174-175.
23. Peterson C., Gibson G.E., Blass J.P. Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease. N. Engl. J. Med. 312:1985;1063-1065.
24. Rogers J., Lue L.F. Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39:2001;333-340.
25. Sevush S., Jy W., Horstman L.L., Mao W.W., Kolodny L., Ahn Y.S. Platelet activation in Alzheimer disease. Arch. Neurol. 55:1998;530-536.
26. Sims N.R., Finegan J.M., Blass J.P. Altered glucose metabolism in fibroblasts from patients with Alzheimer's disease. N. Engl. J. Med. 313:1985;683-684.
27. Soininen H., Syrjanen S., Heinonen O., Neittaanmaki H., Miettinen R., Paljarvi L., Syrjanen K., Beyreuther K., Riekkinen P. Amyloid β-protein deposition in skin of patients with dementia. Lancet. 339:1992;245.
28. Stewart, J.M., Young, J.D., 1984. Solid Phase Peptide Synthesis, 2nd ed. Pierce, Rockford, IL.
29. Stix B., Reiser B. β-Amyloid peptide 25-35 regulates basal and hormone-stimulated Ca-levels in cultured rat astrocytes. Neurosci. Lett. 243:1998;121-124.